J&J Loses $110 Million Verdict Over Talc Cancer-Link Claim

Imerys Talc America ordered by jury to pay about $100,000
J&J denies any link between talc use and ovarian cancer

Bottles of Johnson's baby powder, produced by Johnson & Johnson, sit on display at a Tesco supermarket in London, U.K., on Tuesday, April 19, 2011.
Photographer: Simon Dawson/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Margaret Cronin Fisk and Tim Bross

May 4, 2017 at 11:30 PM UTC

Updated on

May 5, 2017 at 1:10 AM UTC

This article is for subscribers only.

Johnson & Johnson was ordered by a St. Louis jury to pay more than $110 million to a Virginia woman who blamed her ovarian cancer on the company’s talcum products.

Imerys Talc America, which provided the talc to J&J, was ordered by the jury to pay about $100,000. Imerys Talc is a unit of Paris-based Imerys SA.